Kyung Gi Cho

CHA University Bundang Medical Center — South Korea

Medicine · Health Sciences

20h-index1.4kcitations102works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(22), Meningioma and schwannoma management(17), Intracranial Aneurysms: Treatment and Complications(14), Traumatic Brain Injury and Neurovascular Disturbances(11), Vascular Malformations Diagnosis and Treatment(8)

Publications102 total

Corpora Amylacea Mimicking Diffuse Glioma: A Rare Case of Extensive Periventricular Accumulation
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques·2025
Trigeminal Neuralgia with Persistent Trigeminal Artery Variant and Schwannomatosis of the Abducens and Lower Cranial Nerves: A Case Report
Journal of the Korean Society of Radiology·2025Open Access
TMIC-70. CORRELATION OF LLT-1 AND NLRC4 INFLAMMASOME AND ITS EFFECT ON GLIOBLASTOMA PROGNOSIS
Neuro-Oncology·2024Open Access
Correlation of LLT-1 and NLRC4 inflammasome and its effect on glioblastoma prognosis
Journal of Neuro-Oncology·2024· 5 cited
The Inflammatory Characteristics of Symptomatic Glioma Associated With Poor Prognosis and Chemoresistance via Tumor Necrosis Factor Signaling Pathway
Brain Tumor Research and Treatment·2024· 1 citedOpen Access
CTNI-30. MESENCHYMAL STEM CELL (MSC11FCD) BASED THERAPY ELICITED A FAVORABLE RESPONSE WITH EFFICIENT 5-FU CONVERSION IN PATIENTS WITH RECURRENT GLIOBLASTOMA: AN OPEN LABEL, PHASE I/IIA TRIAL
Neuro-Oncology·2023· 3 citedOpen Access
DDDR-20. FOSL1 INDUCES TMZ-CHEMORESISTANCE IN GLIOBLASTOMA VIA REGULATION OF IL-6-STAT3TYR705PATHWAY-MEDIATED STEMNESS
Neuro-Oncology·2023Open Access
Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy
Inflammation Research·2023· 12 cited
First Clinical Report on the Treatment of Parkinson's Disease with Fetal Midbrain Precursor Cells
Movement Disorders·2023· 6 cited
Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy
Cell & Bioscience·2023· 10 citedOpen Access
Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker
Brain Tumor Research and Treatment·2023Open Access
TMIC-11. ASSOCIATION OF TIM-3/GAL-9 AXIS WITHNLRC4 INFLAMMASOME IN GLIOMA MALIGNANCY: TIM-3/GAL-9 INDUCE THE NLRC4 INFLAMMASOME
Neuro-Oncology·2022Open Access
TMET-17. NOX2-INDUCED HIGH GLYCOLYTIC ACTIVITY CONTRIBUTES TO THE GAIN OF COL5A1-MEDIATED MESENCHYMAL PHENOTYPE IN GBM
Neuro-Oncology·2022Open Access
Predictive Biomarkers for the Responsiveness of Recurrent Glioblastomas to Activated Killer Cell Immunotherapy
2022Open Access
Molecular characteristics of incidental lower-grade glioma for treatment decision-making
Journal of neurosurgery·2022· 3 cited
Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome
International Journal of Molecular Sciences·2022· 20 citedOpen Access
NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM
Cancers·2022· 11 citedOpen Access
Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: a phase I/IIa trial
WFNOS 2022 Abstract Book·2022Open Access
NOX2-induced high glycolytic activity promotes heterogeneity by pro-fibrotic phenotype in high-grade glioma
WFNOS 2022 Abstract Book·2022Open Access
Predictive biomarkers for the responsiveness to autologous activated killer cell immunotherapy in recurrent Glioblastomas
WFNOS 2022 Abstract Book·2022Open Access
page 1 of 6Next →

Frequent Co-authors

Jaejoon Lim(16), Soo Han Yoon(9), Ki Hong Cho(8), Yong Sam Shin(6), Ju Won Ahn(6), Young Hwan Ahn(5), Se-Hyuk Kim(5), JeongMin Sim(5), Kyoung Su Sung(5), Se Hyuk Kim(4), Jong‐Seok Moon(4), KyuBum Kwack(4), Sang Heum Kim(4), Yong Sam Shin(3), Seung Up Kim(3), Jang‐Hee Kim(3), Young-Hwan Ahn(3), YoungJoon Park(3), So Jung Hwang(3), Dong Ah Shin(3)